Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 738,886 | 673,805 | 727,566 | 793,361 | 756,564 |
| Marketable Securities | 652 | 460 | 739 | 703 | 763 |
| Receivables | 285,148 | 391,293 | 373,091 | 331,096 | 297,614 |
| Inventories | 30,768 | 31,929 | 31,264 | 30,424 | 32,415 |
| Other current assets | 206,881 | 238,924 | 198,266 | 180,804 | 204,381 |
| TOTAL | $1,326,041 | $1,414,709 | $1,408,062 | $1,388,261 | $1,338,119 |
| Non-Current Assets | |||||
| PPE Net | 459,115 | 461,841 | 466,720 | 470,608 | 478,481 |
| Investments And Advances | 86,437 | 81,220 | 85,022 | 80,205 | 78,017 |
| Intangibles | 910,777 | 919,378 | 894,320 | 926,957 | 936,973 |
| Other Non-Current Assets | 374,232 | 372,346 | 337,999 | 361,729 | 364,411 |
| TOTAL | $1,830,561 | $1,834,785 | $1,784,061 | $1,839,499 | $1,857,882 |
| Total Assets | $3,156,602 | $3,249,494 | $3,192,123 | $3,227,760 | $3,196,001 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,470 | 20,688 | 8,668 | 17,840 | 17,234 |
| Accrued Expenses | 360,407 | 405,200 | 376,212 | 369,256 | 317,422 |
| Other current liabilities | 33,593 | 38,837 | 37,094 | 31,382 | 36,031 |
| TOTAL | $416,329 | $474,606 | $443,507 | $437,790 | $388,785 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 146,946 | 147,217 | 145,391 | 157,702 | 192,494 |
| TOTAL | $147,558 | $147,756 | $145,745 | $158,024 | $192,965 |
| Total Liabilities | $563,887 | $622,362 | $589,252 | $595,814 | $581,750 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 93,669 | 94,598 | 95,540 | 95,506 | 95,844 |
| Common Shares | 92 | 93 | 94 | 94 | 94 |
| Retained earnings | 2,598,923 | 2,630,175 | 2,604,358 | 2,634,980 | 2,618,163 |
| Other shareholders' equity | -6,300 | -3,136 | -1,581 | -3,128 | -4,006 |
| TOTAL | $2,592,715 | $2,627,132 | $2,602,871 | $2,631,946 | $2,614,251 |
| Total Liabilities And Equity | $3,156,602 | $3,249,494 | $3,192,123 | $3,227,760 | $3,196,001 |